These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33893204)

  • 41. Mitochondrial NADH Dehydrogenase Subunit 3 Polymorphism Associated with an Earlier Age at Onset in Male Machado-Joseph disease Patients.
    Chen S; Gan SR; Cai PP; Ni W; Zhou Q; Dong Y; Wang N; Wu ZY
    CNS Neurosci Ther; 2016 Jan; 22(1):38-42. PubMed ID: 26336829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype.
    van Alfen N; Sinke RJ; Zwarts MJ; Gabreëls-Festen A; Praamstra P; Kremer BP; Horstink MW
    Ann Neurol; 2001 Jun; 49(6):805-7. PubMed ID: 11409435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival estimates for patients with Machado-Joseph disease (SCA3).
    Kieling C; Prestes PR; Saraiva-Pereira ML; Jardim LB
    Clin Genet; 2007 Dec; 72(6):543-5. PubMed ID: 17894834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
    Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
    Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia.
    Ranum LP; Lundgren JK; Schut LJ; Ahrens MJ; Perlman S; Aita J; Bird TD; Gomez C; Orr HT
    Am J Hum Genet; 1995 Sep; 57(3):603-8. PubMed ID: 7668288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent therapeutic prospects for Machado-Joseph disease.
    Costa MDC
    Curr Opin Neurol; 2020 Aug; 33(4):519-526. PubMed ID: 32657894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Explainable artificial intelligence based on feature optimization for age at onset prediction of spinocerebellar ataxia type 3.
    Ru D; Li J; Xie O; Peng L; Jiang H; Qiu R
    Front Neuroinform; 2022; 16():978630. PubMed ID: 36110986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of human iPS cell line IBCHi002-A from spinocerebellar ataxia type 3/Machado-Joseph disease patient's fibroblasts.
    Ciolak A; Krzyzosiak WJ; Kozlowska E; Fiszer A
    Stem Cell Res; 2020 May; 45():101796. PubMed ID: 32361312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths.
    Netravathi M; Pal PK; Purushottam M; Thennarasu K; Mukherjee M; Jain S
    J Neurol Sci; 2009 Feb; 277(1-2):83-6. PubMed ID: 19049837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.
    Ramani B; Panwar B; Moore LR; Wang B; Huang R; Guan Y; Paulson HL
    Hum Mol Genet; 2017 Sep; 26(17):3362-3374. PubMed ID: 28854700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD).
    Klockgether T; Schöls L; Abele M; Bürk K; Topka H; Andres F; Amoiridis G; Lüdtke R; Riess O; Laccone F; Dichgans J
    J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):222-4. PubMed ID: 10071104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Detection of the CAG trinucleotide repeats of MJD1 gene by recombinant DNA technology].
    Zhang S; Wang JL; Xu Q; Li XH; Lei LF; Jiang H; Shen L; Yan XX; Pan Q; Xia K; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):406-9. PubMed ID: 20017304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calpain Inhibition Is Protective in Machado-Joseph Disease Zebrafish Due to Induction of Autophagy.
    Watchon M; Yuan KC; Mackovski N; Svahn AJ; Cole NJ; Goldsbury C; Rinkwitz S; Becker TS; Nicholson GA; Laird AS
    J Neurosci; 2017 Aug; 37(32):7782-7794. PubMed ID: 28687604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis.
    de Mattos EP; Kolbe Musskopf M; Bielefeldt Leotti V; Saraiva-Pereira ML; Jardim LB
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):203-210. PubMed ID: 30337442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Recent advances in molecular genetics of spinocerebellar ataxia type 3/Machado-Joseph disease].
    Jia D; Jiang H; Tang B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):660-2. PubMed ID: 19065526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population genetics of wild-type CAG repeats in the Machado-Joseph disease gene in Portugal.
    Lima M; Costa MC; Montiel R; Ferro A; Santos C; Silva C; Bettencourt C; Sousa A; Sequeiros J; Coutinho P; Maciel P
    Hum Hered; 2005; 60(3):156-63. PubMed ID: 16340213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of SCA2 and SCA3/MJD repeats in Parkinson's disease in mainland China: genetic, clinical, and positron emission tomography findings.
    Wang JL; Xiao B; Cui XX; Guo JF; Lei LF; Song XW; Shen L; Jiang H; Yan XX; Pan Q; Long ZG; Xia K; Tang BS
    Mov Disord; 2009 Oct; 24(13):2007-11. PubMed ID: 19672991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a potential exosomal biomarker in spinocerebellar ataxia Type 3/Machado-Joseph disease.
    Hou X; Gong X; Zhang L; Li T; Yuan H; Xie Y; Peng Y; Qiu R; Xia K; Tang B; Jiang H
    Epigenomics; 2019 Jul; 11(9):1037-1056. PubMed ID: 31144508
    [No Abstract]   [Full Text] [Related]  

  • 60. [SCA1, SCA2, MJD/SCA3 (CAG)n mutation detection and analysis in patients with hereditary spinocerebellar ataxia from Chinese families].
    Tang B; Wang D; Xia J
    Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):819-22. PubMed ID: 9772474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.